Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer: Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop
- 1 February 2015
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 10 (2), 237-249
- https://doi.org/10.1097/jto.0000000000000412
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- New strategy for monitoring targeted therapy: molecular imagingInternational Journal of Nanomedicine, 2013
- Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancerFrontiers in Oncology, 2013
- Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECISTAmerican Journal of Roentgenology, 2012
- Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?Korean Journal of Radiology, 2012
- Imaging of Lung Cancer in the Era of Molecular MedicineAcademic Radiology, 2011
- CT Tumor Volume Measurement in Advanced Non-small-cell Lung Cancer: Performance Characteristics of an Emerging Clinical ToolAcademic Radiology, 2011
- Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?European Radiology, 2010
- Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung CancerRadiology, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET)PLOS ONE, 2008